TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 15170931

Group type: EXPERIMENTAL
Intervention: Preoperative exercise/education program (4-week duration)
Number of subjects: 131

Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 131
Study: 11269462

Group type: EXPERIMENTAL
Intervention: Low-dose aprotinin (2 x 10(6) kallikrein inhibitor units)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Epsilon aminocaproic acid (EACA) (20 g)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Low-dose aprotinin
Number of subjects: 100

Group type: COMPARATOR
Intervention: Epsilon aminocaproic acid (EACA)
Number of subjects: 100
Study: 9505147

Group type: EXPERIMENTAL
Intervention: Metformin treatment for 12 weeks
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (diet and lifestyle advice and lovastatin 40 mg/dag during a 4-week run-in period)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Non-obese patients receiving Metformin
Number of subjects: 60
Study: 8141225

Group type: EXPERIMENTAL
Intervention: Intrapartum chemoprophylaxis
Number of subjects: 9

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 9
Study: 2643167

Group type: EXPERIMENTAL
Intervention: Nisoldipine 10 to 20 mg once daily
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 125147

Group type: EXPERIMENTAL
Intervention: Streptozotocin (0.5 g/m IV weekly)
Number of subjects: 197

Group type: EXPERIMENTAL
Intervention: CCNU (130 mg/m orally every 6 weeks)
Number of subjects: 197

Group type: EXPERIMENTAL
Intervention: 6-Thioguanine (1.0 mg/kg/day orally)
Number of subjects: 197

Group type: EXPERIMENTAL
Intervention: Procarbazine (3 mg/kg/day orally)
Number of subjects: 197
Study: 30745073

Group type: EXPERIMENTAL
Intervention: Vitamin E
Number of subjects: 150

Group type: COMPARATOR
Intervention: Chlorhexidine
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Honey
Number of subjects: 150
Study: 27879567

Group type: EXPERIMENTAL
Intervention: Collar-fixation (CF) group - postoperative Philadelphia collar for 2 weeks
Number of subjects: 74

Group type: COMPARATOR
Intervention: No-collar (NC) group
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Collar-fixation (CF) group
Number of subjects: 74
Study: 26126178

Group type: EXPERIMENTAL
Intervention: Universal prevention intervention
Number of subjects: 1874
Study: 23867417

Group type: EXPERIMENTAL
Intervention: Low-frequency (1 Hz) rTMS applied for 20 min per day over 10 days
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo control
Number of subjects: 12
Study: 21807138

Group type: EXPERIMENTAL
Intervention: Expert Patient Programme (EPP) plus usual care
Number of subjects: 64

Group type: COMPARATOR
Intervention: Usual care only
Number of subjects: 64
Study: 19249421

Group type: EXPERIMENTAL
Intervention: Fondaparinux
Number of subjects: 3

Group type: COMPARATOR
Intervention: Enoxaparin
Number of subjects: 3
Study: 15920566

Group type: EXPERIMENTAL
Intervention: 4 ml lignocaine 2% with sodium hyaluronidase 75 IU/ml (Group B)
Number of subjects: 60

Group type: COMPARATOR
Intervention: 4 ml lignocaine 2% (Group A)
Number of subjects: 60
Study: 15287198

Group type: EXPERIMENTAL
Intervention: Bicarbonate-buffered replacement fluid
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Lactate-buffered replacement fluid
Number of subjects: 8
Study: 11239280

Group type: EXPERIMENTAL
Intervention: Action Research Arm (ARA) test
Number of subjects: 20
Study: 9570604

Group type: EXPERIMENTAL
Intervention: Lidocaine 100 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Bupivacaine 15 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Tetracaine 15 mg
Number of subjects: 12
Study: 8072050

Group type: EXPERIMENTAL
Intervention: High-dose methadone (80 mg)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Low-dose methadone (40 mg)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Both high-dose and low-dose methadone
Number of subjects: 38
Study: 2468872

Group type: EXPERIMENTAL
Intervention: Nitrendipine (20 mg single oral daily dose for a 3‐week treatment period)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Nitrendipine
Number of subjects: 20
Study: 31519680

Group type: EXPERIMENTAL
Intervention: Enhanced community case management (CCM) plus monthly screening and treatment (MSAT) using rapid diagnostic tests (RDTs)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Standard of care plus enhanced CCM, comprising active weekly screening for fever and detection and treatment of infections in fever positive individuals using RDTs
Number of subjects: 180

Group type: COMPARATOR
Intervention: Current standard of care with passively monitored malaria infections
Number of subjects: 180
Study: 28738788

Group type: EXPERIMENTAL
Intervention: Magnesium sulfate for 6 hours postpartum
Number of subjects: 284

Group type: COMPARATOR
Intervention: Magnesium sulfate for 24 hours postpartum
Number of subjects: 284
Study: 26711317

Group type: EXPERIMENTAL
Intervention: rAAV2-NRTN
Number of subjects: 53
Study: 25349302

Group type: EXPERIMENTAL
Intervention: Tamoxifen plus ovarian function suppression (OFS)
Number of subjects: 345

Group type: COMPARATOR
Intervention: Tamoxifen alone
Number of subjects: 345
Study: 22537222

Group type: EXPERIMENTAL
Intervention: 12-month intervention consisting of tailored obesogenic behavior change goals, self-monitoring via interactive voice response phone calls, tailored skills training materials, 12 counseling calls with a registered dietitian, and a 12-month YMCA membership.
Number of subjects: 194

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 194
Study: 20006254

Group type: EXPERIMENTAL
Intervention: Group S7.5 (1.5 mL of 0.5% hyperbaric bupivacaine)
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: Group S5 (1.0 mL of 0.5% hyperbaric bupivacaine)
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: Group S4 (0.8 mL of 0.5% hyperbaric bupivacaine)
Number of subjects: 152
Study: 17326076

Group type: EXPERIMENTAL
Intervention: Automated framework for identifying regions of anatomical abnormality in MR images and using them as seed points for fiber tracking with DTI.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Automated algorithm for volume-preserved warping (VPW) and fiber tracking.
Number of subjects: 0
Study: 15125183

Group type: EXPERIMENTAL
Intervention: Latanoprost 0.005% once daily
Number of subjects: 60

Group type: COMPARATOR
Intervention: Dorzolamide 2% three times daily
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Comparison of both interventions
Number of subjects: 60
Study: 11213002

Group type: EXPERIMENTAL
Intervention: Two-stage repair leaving the skin unsutured
Number of subjects: 793

Group type: EXPERIMENTAL
Intervention: Polyglactin 910
Number of subjects: 793

Group type: COMPARATOR
Intervention: Standard three-stage repair
Number of subjects: 793

Group type: COMPARATOR
Intervention: Chromic catgut
Number of subjects: 793
Study: 9751631

Group type: EXPERIMENTAL
Intervention: High-dose cytarabine (3 g/m2)
Number of subjects: 285

Group type: EXPERIMENTAL
Intervention: Intermediate-dose cytarabine (400 mg/m2)
Number of subjects: 285

Group type: EXPERIMENTAL
Intervention: Low-dose cytarabine (100 mg/m2)
Number of subjects: 285

Group type: COMPARATOR
Intervention: All doses of cytarabine
Number of subjects: 285
Study: 7851109

Group type: EXPERIMENTAL
Intervention: Initial data entry
Number of subjects: 44

Group type: COMPARATOR
Intervention: Double data entry
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Vital/important error rate
Number of subjects: 44
Study: 3289550

Group type: EXPERIMENTAL
Intervention: Midazolam (15 mg)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Triazolam (0.5 mg)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 31975496

Group type: EXPERIMENTAL
Intervention: Istaroxime 0.5 μg/kg/min
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Istaroxime 1.0 μg/kg/min
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Istaroxime (both doses)
Number of subjects: 99

Group type: COMPARATOR
Intervention: Istaroxime and placebo (all groups)
Number of subjects: 99

Group type: COMPARATOR
Intervention: Istaroxime and placebo
Number of subjects: 99
Study: 30944022

Group type: EXPERIMENTAL
Intervention: Trial managers' unguided recruitment predictions
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Red flags for recruitment failure identified by trial managers
Number of subjects: 56
Study: 26850796

Group type: EXPERIMENTAL
Intervention: Facial acupuncture
Number of subjects: 41

Group type: COMPARATOR
Intervention: Facial/body acupuncture
Number of subjects: 41
Study: 24418042

Group type: EXPERIMENTAL
Intervention: One-on-one teaching (1-1)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Group teaching (GT)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Both groups (1-1 and GT)
Number of subjects: 16
Study: 22568569

Group type: EXPERIMENTAL
Intervention: Personalized cognitive counseling (PCC)
Number of subjects: 374

Group type: COMPARATOR
Intervention: Standard risk-reduction counseling (control)
Number of subjects: 374
Study: 20798194

Group type: EXPERIMENTAL
Intervention: Epoetin alfa (10,000 IU 3 times weekly)
Number of subjects: 223

Group type: COMPARATOR
Intervention: Best standard care (BSC)
Number of subjects: 223
Study: 18756431

Group type: EXPERIMENTAL
Intervention: 17alpha-hydroxyprogesterone caproate (17P), 341 mg intramuscularly, twice a week until 36 weeks
Number of subjects: 45

Group type: COMPARATOR
Intervention: Observation (Control)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: 17alpha-hydroxyprogesterone caproate (17P)
Number of subjects: 45
Study: 15811049

Group type: EXPERIMENTAL
Intervention: Listerine Antiseptic (30 s rinse)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Sterile water control (30 s rinse)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Listerine Antiseptic (60 min post rinse follow-up)
Number of subjects: 40
Study: 12835206

Group type: EXPERIMENTAL
Intervention: Transplant vasculopathy subjects
Number of subjects: 15

Group type: COMPARATOR
Intervention: No angiographic evidence of disease subjects
Number of subjects: 15
Study: 10925686

Group type: EXPERIMENTAL
Intervention: HCFU 100 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: 5-FU 250 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: 5-FU 500 mg
Number of subjects: 0
Study: 8893355

Group type: EXPERIMENTAL
Intervention: Constant inflow (CFlow) administration
Number of subjects: 7

Group type: COMPARATOR
Intervention: Constant fraction (CF) administration
Number of subjects: 7
Study: 8457158

Group type: EXPERIMENTAL
Intervention: Postoperative infection
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Postoperative fever without documented infection
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Infected patients
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Use of departmental cost‐charge ratios
Number of subjects: 0
Study: 2431395

Group type: EXPERIMENTAL
Intervention: Thymostimulin (TP‐1 Serono: 1.5 mg/kg/die for five days)
Number of subjects: 28

Group type: COMPARATOR
Intervention: No treatment (control group)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Thymostimulin (TP‐1 Serono)
Number of subjects: 28
Study: 30111357

Group type: EXPERIMENTAL
Intervention: PF-06410293
Number of subjects: 597

Group type: COMPARATOR
Intervention: adalimumab-EU
Number of subjects: 597
Study: 24076045

Group type: EXPERIMENTAL
Intervention: High-intensity aerobic bicycling exercises
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Low-intensity aerobic bicycling exercises
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Isometric muscle contraction exercises (arm and leg)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Cold pressor tests (hand and foot)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Exercise (general)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Cold pressor tests (general)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Conditioned pain modulation (CPM)
Number of subjects: 80
Study: 22539584

Group type: EXPERIMENTAL
Intervention: Oral glucose challenge (75-g glucose tolerance test)
Number of subjects: 59
Study: 20077149

Group type: EXPERIMENTAL
Intervention: Family intervention (three-session family intervention)
Number of subjects: 173

Group type: COMPARATOR
Intervention: Mailers to engage families
Number of subjects: 173

Group type: COMPARATOR
Intervention: Assessment data provided to clinicians
Number of subjects: 173

Group type: COMPARATOR
Intervention: Organizational support for family services
Number of subjects: 173
Study: 17907110

Group type: EXPERIMENTAL
Intervention: Tesaglitazar (0.5 or 1 mg/day)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 16287387

Group type: EXPERIMENTAL
Intervention: Brief intervention (5 to 45 min)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 76
Study: 12180212

Group type: EXPERIMENTAL
Intervention: Telemedicine system for fracture diagnosis by OMFS doctors
Number of subjects: 16

Group type: COMPARATOR
Intervention: Plain radiography
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Telemedicine system
Number of subjects: 16
Study: 10616948

Group type: EXPERIMENTAL
Intervention: Right Unilateral ECT (RUL) with age-based dosing (5.0 mC per year)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Right Unilateral ECT (RUL) with fixed high dose (378 mC)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Bifrontal ECT (BF) with age-based dosing
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Dose-titration method
Number of subjects: 80
Study: 7543328

Group type: EXPERIMENTAL
Intervention: Laser prostatectomy
Number of subjects: 0
Study: 2754281

Group type: EXPERIMENTAL
Intervention: 1 microgram/day alfacalcidol for 9.67 months
Number of subjects: 24

Group type: COMPARATOR
Intervention: Non-treated group observed for 9.92 months
Number of subjects: 24
Study: 9967

Group type: EXPERIMENTAL
Intervention: Lorazepam (2.5 mg)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Medazepam (15 mg)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Diazepam (10 mg)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study: 31447130

Group type: EXPERIMENTAL
Intervention: Mepolizumab 100 mg subcutaneously every 4 weeks for up to 172 weeks
Number of subjects: 340
Study: 28719592

Group type: EXPERIMENTAL
Intervention: TL quadruple therapy (esomeprazole 40 mg b.d., bismuth 120 mg q.d.s., tetracycline 500 mg q.d.s., and levofloxacin 500 mg o.d.)
Number of subjects: 102

Group type: COMPARATOR
Intervention: AL triple therapy (esomeprazole 40 mg b.d., amoxicillin 500 mg q.d.s., and levofloxacin 500 mg o.d.)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: TL quadruple therapy
Number of subjects: 102

Group type: COMPARATOR
Intervention: AL triple therapy
Number of subjects: 102
Study: 25315022

Group type: EXPERIMENTAL
Intervention: LED therapy (625 nm, 4 J/cm²) with Unna's boot
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo treatment with Unna's boot (Control)
Number of subjects: 17
Study: 23742915

Group type: EXPERIMENTAL
Intervention: Reciprocal Actions (RA)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Superset (SS)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Multiple Set (MS)
Number of subjects: 24
Study: 21284982

Group type: EXPERIMENTAL
Intervention: Dietary inorganic nitrate supplementation
Number of subjects: 0
Study: 19485990

Group type: EXPERIMENTAL
Intervention: Isosorbide mononitrate (IMN)
Number of subjects: 350

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 350
Study: 16816054

Group type: EXPERIMENTAL
Intervention: 0.625 mg/d of conjugated estrogens (n = 20)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Gabapentin titrated to 2,400 mg/d (n = 20)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo (n = 20)
Number of subjects: 60
Study: 12777548

Group type: EXPERIMENTAL
Intervention: Parenting education program (intervention group)
Number of subjects: 286

Group type: EXPERIMENTAL
Intervention: Parenting education program (intervention group) with 30+ contacts
Number of subjects: 286

Group type: COMPARATOR
Intervention: Standard social services (control group)
Number of subjects: 286
Study: 11235451

Group type: EXPERIMENTAL
Intervention: Aseptic, non‐touch technique
Number of subjects: 79

Group type: COMPARATOR
Intervention: Sterile technique
Number of subjects: 79
Study: 9101193

Group type: EXPERIMENTAL
Intervention: CGP 48933
Number of subjects: 10

Group type: COMPARATOR
Intervention: Saline (vehicle)
Number of subjects: 10
Study: 7906659

Group type: EXPERIMENTAL
Intervention: azelastine nasal spray (0.14 mg/nostril administered twice daily)
Number of subjects: 30

Group type: COMPARATOR
Intervention: loratidine tablets (10 mg once daily)
Number of subjects: 30
Study: 3106208

Group type: EXPERIMENTAL
Intervention: 3.5% amino-acid solution with 6% carbohydrates
Number of subjects: 20

Group type: COMPARATOR
Intervention: Water and electrolytes
Number of subjects: 20
Study: 29316405

Group type: EXPERIMENTAL
Intervention: Magnesium-zinc-calcium-vitamin D co-supplements
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 27542731

Group type: EXPERIMENTAL
Intervention: Baclofen
Number of subjects: 314

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 314
Study: 25470975

Group type: EXPERIMENTAL
Intervention: Dengzhanhua injection and Xiongqin injection combined with Xuesaitong
Number of subjects: 140

Group type: COMPARATOR
Intervention: Xuesaitong
Number of subjects: 140
Study: 22721656

Group type: EXPERIMENTAL
Intervention: Percutaneous coronary intervention (PCI)
Number of subjects: 3075

Group type: EXPERIMENTAL
Intervention: Coronary artery bypass grafting (CABG)
Number of subjects: 3075
Study: 20457688

Group type: EXPERIMENTAL
Intervention: Research study offering improved outcomes
Number of subjects: 4685

Group type: COMPARATOR
Intervention: Research study offering only reductions in risk for adverse effects
Number of subjects: 4685

Group type: COMPARATOR
Intervention: Research study scenarios with the same risks but less benefit
Number of subjects: 4685

Group type: EXPERIMENTAL
Intervention: Parental sociodemographics and numeracy
Number of subjects: 4685
Study: 18511528

Group type: EXPERIMENTAL
Intervention: COM
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: END
Number of subjects: 46

Group type: COMPARATOR
Intervention: C
Number of subjects: 46
Study: 16198843

Group type: EXPERIMENTAL
Intervention: Flavanol-rich cocoa (176 to 185 mg flavanols)
Number of subjects: 11

Group type: COMPARATOR
Intervention: L-NMMA (NO-synthase inhibitor)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Ascorbic acid
Number of subjects: 11
Study: 15195981

Group type: EXPERIMENTAL
Intervention: Foster Grandparent Program
Number of subjects: 52

Group type: COMPARATOR
Intervention: Control groups (not specified)
Number of subjects: 52
Study: 10569666

Group type: EXPERIMENTAL
Intervention: Cilostazol with aspirin
Number of subjects: 50

Group type: COMPARATOR
Intervention: Aspirin alone
Number of subjects: 50
Study: 8753934

Group type: EXPERIMENTAL
Intervention: Caffeine (3 mg/kg body weight)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Lactose (control)
Number of subjects: 0
Study: 1877264

Group type: EXPERIMENTAL
Intervention: Fluconazole
Number of subjects: 185

Group type: COMPARATOR
Intervention: Clotrimazole
Number of subjects: 185
Study: 6211147

Group type: EXPERIMENTAL
Intervention: Heat‐killed sonicated suspension of malassezia ovalis
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Heat‐killed sonicated suspension of Staphylococcus epidermidis
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Clinical and histological lesions consistent with psoriasis
Number of subjects: 20
Study: 31784435

Group type: EXPERIMENTAL
Intervention: Mikono Safi intervention (multi-modal school-based WASH intervention)
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: Mikono Safi intervention
Number of subjects: 116
Study: 29850709

Group type: EXPERIMENTAL
Intervention: Açaí beverage (325 mL twice per day for 12 weeks)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Placebo control (325 mL twice per day for 12 weeks)
Number of subjects: 37
Study: 27565010

Group type: EXPERIMENTAL
Intervention: Methylene blue (MB) injection, 1ml of 0.5% solution
Number of subjects: 50

Group type: COMPARATOR
Intervention: Normal saline (control)
Number of subjects: 50
Study: 25192389

Group type: EXPERIMENTAL
Intervention: Antibiotics
Number of subjects: 1037
Study: 22828021

Group type: EXPERIMENTAL
Intervention: Preventive antiemetic medication
Number of subjects: 1151

Group type: EXPERIMENTAL
Intervention: Number of significant risk factors
Number of subjects: 1151

Group type: EXPERIMENTAL
Intervention: Preventive antiemetic medication administration
Number of subjects: 1151
Study: 19944870

Group type: EXPERIMENTAL
Intervention: Early recovery telehealth intervention (6 weeks)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 55

Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 55
Study: 17486385

Group type: EXPERIMENTAL
Intervention: Six hours of classroom instruction and workshop time with professors of theater.
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (not specified intervention).
Number of subjects: 20
Study: 14711543

Group type: EXPERIMENTAL
Intervention: 0.1 microM FF-MAS in 0.2% ethanol
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: 1 microM FF-MAS in 0.2% ethanol
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: 10 microM FF-MAS in 0.2% ethanol
Number of subjects: 210

Group type: COMPARATOR
Intervention: 0.2% ethanol
Number of subjects: 210

Group type: COMPARATOR
Intervention: Water for injection (control)
Number of subjects: 210
Study: 11403366

Group type: EXPERIMENTAL
Intervention: Irbesartan (150 mg/day)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 9693999

Group type: EXPERIMENTAL
Intervention: Sodium lactate infusion
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo (0.9% saline) infusion
Number of subjects: 20

Group type: COMPARATOR
Intervention: 2.5% saline infusion
Number of subjects: 20
Study: 8164080

Group type: EXPERIMENTAL
Intervention: Auscultatory percussion (AP) examination
Number of subjects: 293

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 293
Study: 3276864

Group type: EXPERIMENTAL
Intervention: Clindamycin (20 mg/kg/d at 8-hour intervals for 10 to 14 days)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Ampicillin, gentamicin, and clindamycin
Number of subjects: 42

Group type: COMPARATOR
Intervention: Ampicillin and gentamicin (control group)
Number of subjects: 42